Publication | Open Access

Survivorship in immune therapy: Assessing toxicities, body composition and health-related quality of life among long-term survivors treated with antibodies to programmed death-1 receptor and its ligand

Autoimmune DiseaseImmunotoxicologyDeath-1 ReceptorImmune RegulationImmunologyEnd-of-life IssueImmune Checkpoint InhibitorSelf-toleranceAutoimmunityImmune TherapyTerminal IllnessImmunotherapyMedicineLong-term Survivors